UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

527: Implementation of multidisciplinary policy to improve outcomes for women with morbidly adherent placental disease

American journal of obstetrics and gynecology, 2020-01, Vol.222 (1), p.S340-S340

2020

Volltextzugriff (PDF)

Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery

Radiation oncology (London, England), 2021-06, Vol.16 (1), p.123-123, Article 123

2021

Volltextzugriff (PDF)

Association between sentinel lymph node biopsy and micrometastasis in endometrial cancer

European journal of obstetrics & gynecology and reproductive biology, 2022-08, Vol.275, p.91-96

2022

Volltextzugriff (PDF)

Clinical Implications of Marker Expression of Carcinoma-Associated Fibroblasts (CAFs) in Patients with Epithelial Ovarian Carcinoma After Treatment with Neoadjuvant Chemotherapy

Cancer microenvironment, 2014-08, Vol.7 (1-2), p.33-39

2014

Volltextzugriff (PDF)

Correction to: Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery

Radiation oncology (London, England), 2021-08, Vol.16 (1), p.1-162, Article 162

2021

Volltextzugriff (PDF)

Endoplasmic reticulum stress in complex atypical hyperplasia as a possible predictor of occult carcinoma and progestin response

Gynecologic oncology, 2016-12, Vol.143 (3), p.650-654

2016

Volltextzugriff (PDF)

Endoplasmic reticulum stress within complex atypical hyperplasia may predict occult endometrial malignancy

Gynecologic oncology, 2013-10, Vol.131 (1), p.252-253

2013

Volltextzugriff (PDF)

Histologic Parameters Predictive of Disease Outcome in Women with Advanced Stage Ovarian Carcinoma Treated with Neoadjuvant Chemotherapy

Translational oncology, 2012-12, Vol.5 (6), p.469-474

2012

Volltextzugriff (PDF)

Histologic Parameters Predictive of Disease Outcome in Women with Advanced Stage Ovarian Carcinoma Treated with Neoadjuvant Chemotherapy1

Translational oncology, 2012-12, Vol.5 (6), p.469-474

2012

Volltextzugriff (PDF)

Implementation of multidisciplinary practice change to improve outcomes for women with placenta accreta spectrum

European journal of obstetrics & gynecology and reproductive biology, 2020-03, Vol.246, p.194-196

2020

Volltextzugriff (PDF)

Increasing utilization of neoadjuvant chemotherapy for stage IVB endometrial cancer (464)

Gynecologic oncology, 2022-08, Vol.166, p.S231

2022

Volltextzugriff (PDF)

Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C

Clinical immunology (Orlando, Fla.), 2015-12, Vol.161 (2), p.197-208

2015

Volltextzugriff (PDF)

Long‐Term Pegylated Liposomal Doxorubicin Use and Oromaxillary Squamous Cell Carcinoma in Endometrial Cancer

The oncologist (Dayton, Ohio), 2012-12, Vol.17 (12), p.1598-1599

2012

Volltextzugriff (PDF)

Microfocus of Anaplastic Carcinoma Arising in Mural Nodule of Ovarian Mucinous Borderline Tumor With Very Rapid and Fatal Outcome

International journal of gynecological pathology, 2016-07, Vol.35 (4), p.348

2016

Volltextzugriff (PDF)

Non-prescription cannabis use for symptom management amongst women with gynecologic malignancies

Gynecologic oncology reports, 2019-11, Vol.30, p.100497-100497, Article 100497

2019

Volltextzugriff (PDF)

Our Space of Morrow

International journal of gynecological cancer, 2022-12, Vol.32 (12), p.1634-1634

2022

Volltextzugriff (PDF)

Overexpression of HOMER2 predicts better outcome in low-grade endometrioid endometrial adenocarcinoma

Pathology, 2018-08, Vol.50 (5), p.499-503

2018

Volltextzugriff (PDF)

Patient compliance for postoperative radiotherapy and survival outcome of women with stage I endometrioid endometrial cancer

Journal of surgical oncology, 2017-09, Vol.116 (4), p.482-491

2017

Volltextzugriff (PDF)

Phase II clinical trial of eribulin (E) in advanced/recurrent cervical cancer

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.5526-5526

2018

Volltextzugriff (PDF)

Phase II clinical trial of eribulin in advanced or recurrent cervical cancer (CC)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.TPS5617-TPS5617

2015

Volltextzugriff (PDF)

Phase II trial of eribulin in advanced/recurrent cervical cancer

Gynecologic oncology, 2021-08, Vol.162, p.S69-S70

2021

Volltextzugriff (PDF)

Population characteristics in cervical cancer trials: Search for external validity

American journal of obstetrics and gynecology, 2005-02, Vol.192 (2), p.407-413

2005

Volltextzugriff (PDF)

Population-level uptake of neoadjuvant chemotherapy for stage IVB endometrial cancer

Gynecologic oncology, 2022-06, Vol.165 (3), p.428-436

2022

Volltextzugriff (PDF)

Predictive Factor of Conversion to Laparotomy in Minimally Invasive Surgical Staging for Endometrial Cancer

International journal of gynecological cancer, 2016-02, Vol.26 (2), p.290-300

2016

Volltextzugriff (PDF)

Predictive model of venous thromboembolism in endometrial cancer

Gynecologic oncology, 2013-03, Vol.128 (3), p.544-551

2013

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(37)
Buchkapitel
(2)

Sprache

Englisch
(39)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Obstetrics & Gynecology
(16)
Oncology
(16)
Female
(14)
Humans
(14)
Middle Aged
(10)
Adult
(8)
Endometrial Cancer
(8)
Neoplasm Staging
(7)
Hysterectomy
(6)
Retrospective Studies
(6)
Cervical Cancer
(5)
Endometrial Neoplasms - Pathology
(5)
Obstetrics And Gynecology
(5)
Aged
(4)
Hematology, Oncology And Palliative Medicine
(4)
Surgery
(4)
Carcinoma, Endometrioid - Pathology
(3)
Chemotherapy
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

527: Implementation of multidisciplinary policy to improve outcomes for women with morbidly adherent placental disease

Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery

Association between sentinel lymph node biopsy and micrometastasis in endometrial cancer

Clinical Implications of Marker Expression of Carcinoma-Associated Fibroblasts (CAFs) in Patients with Epithelial Ovarian Carcinoma After Treatment with Neoadjuvant Chemotherapy

Correction to: Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery

Endoplasmic reticulum stress in complex atypical hyperplasia as a possible predictor of occult carcinoma and progestin response

Endoplasmic reticulum stress within complex atypical hyperplasia may predict occult endometrial malignancy

Histologic Parameters Predictive of Disease Outcome in Women with Advanced Stage Ovarian Carcinoma Treated with Neoadjuvant Chemotherapy

Histologic Parameters Predictive of Disease Outcome in Women with Advanced Stage Ovarian Carcinoma Treated with Neoadjuvant Chemotherapy1

Implementation of multidisciplinary practice change to improve outcomes for women with placenta accreta spectrum

Increasing utilization of neoadjuvant chemotherapy for stage IVB endometrial cancer (464)

Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C

Long‐Term Pegylated Liposomal Doxorubicin Use and Oromaxillary Squamous Cell Carcinoma in Endometrial Cancer

Microfocus of Anaplastic Carcinoma Arising in Mural Nodule of Ovarian Mucinous Borderline Tumor With Very Rapid and Fatal Outcome

Non-prescription cannabis use for symptom management amongst women with gynecologic malignancies

Our Space of Morrow

Overexpression of HOMER2 predicts better outcome in low-grade endometrioid endometrial adenocarcinoma

Patient compliance for postoperative radiotherapy and survival outcome of women with stage I endometrioid endometrial cancer

Phase II clinical trial of eribulin (E) in advanced/recurrent cervical cancer

Phase II clinical trial of eribulin in advanced or recurrent cervical cancer (CC)

Phase II trial of eribulin in advanced/recurrent cervical cancer

Population characteristics in cervical cancer trials: Search for external validity

Population-level uptake of neoadjuvant chemotherapy for stage IVB endometrial cancer

Predictive Factor of Conversion to Laparotomy in Minimally Invasive Surgical Staging for Endometrial Cancer

Predictive model of venous thromboembolism in endometrial cancer

Suchergebnisse filtern